CL earnings analysis
What we found in CL's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Colgate-Palmolive reported Q1 2026 earnings with revenue of $5.324 billion, exceeding estimates of $5.212 billion, but EPS fell short at $0.80 against an expected $0.95. The company highlighted strong sales growth in Latin America and EMEA, offsetting a decline in North American sales. Full-year guidance for organic sales growth remains intact despite a revised gross margin expectation.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Surpassed Estimates
- Total revenue for Q1 2026 reached $5.324 billion, exceeding the estimated $5.212 billion.
- EPS Missed Expectations
- Diluted EPS reported at $0.80, falling short of the estimated $0.95.
- Strong Latin America Growth
- Sales in Latin America grew by 14.8%, reflecting robust demand.
- Stable Gross Margin Percentage
- Gross margin remained stable at 60.1%, despite previous expectations of a decline.
- Market Share Efforts
- The company continues to focus on strategic initiatives to bolster market share amid competitive pressures.
- Increased Sales in EMEA
- EMEA segment sales rose by 11.9%, contributing to overall growth.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- North American Sales Decline
- Sales in North America declined by 1.8%, indicating potential weakness in this key market.
- Strategic Initiative Costs
- Increased charges from strategic growth initiatives may impact profitability going forward.
- Exit from Pet Food Business
- The ongoing negative impact from the strategic exit from the pet food business may affect future sales.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.8
- Gross margin
- 60.1%
- Operating margin
- 21.2%
What they said about what is next.
Full-year guidance for net sales growth maintained at 2% to 6% and organic sales growth at 1% to 4%, though gross margin outlook was revised down.
The filing reads about the same as the one before it.
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CL makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever